101 related articles for article (PubMed ID: 27057634)
1. DNA polymerase iota (Pol ι) promotes invasion and metastasis of esophageal squamous cell carcinoma.
Zou S; Shang ZF; Liu B; Zhang S; Wu J; Huang M; Ding WQ; Zhou J
Oncotarget; 2016 May; 7(22):32274-85. PubMed ID: 27057634
[TBL] [Abstract][Full Text] [Related]
2. Tumor Cell-Derived Complement Component C1r Acts as a Prognostic Biomarker and Promotes Esophageal Squamous Cell Carcinoma Progression.
Tang M; Zhao S; Ren L; Li Q; Li L; Wang C; Meng C; Chen Y; Hu W
Front Biosci (Landmark Ed); 2024 Apr; 29(4):138. PubMed ID: 38682192
[TBL] [Abstract][Full Text] [Related]
3. SPI1-Mediated Upregulation of the
Luo FF; Wang J; Zhang ZF; Lin ST; Huang TJ; Liu BQ; Fan ML; Peng LX; Zheng ST; Yang CF; Huang BJ
Front Biosci (Landmark Ed); 2023 Sep; 28(9):212. PubMed ID: 37796690
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of matrix metalloproteinase-9 expression in esophageal squamous cell carcinoma.
Gu ZD; Chen KN; Li M; Gu J; Li JY
World J Gastroenterol; 2005 Feb; 11(6):871-4. PubMed ID: 15682484
[TBL] [Abstract][Full Text] [Related]
5. Aberrant MCM10 SUMOylation induces genomic instability mediated by a genetic variant associated with survival of esophageal squamous cell carcinoma.
Tian J; Lu Z; Niu S; Zhang S; Ying P; Wang L; Zhang M; Cai Y; Dong T; Zhu Y; Zhong R; Wang Z; Chang J; Miao X
Clin Transl Med; 2021 Jun; 11(6):e485. PubMed ID: 34185429
[TBL] [Abstract][Full Text] [Related]
6. DNA Polymerase Iota Promotes Esophageal Squamous Cell Carcinoma Proliferation Through Erk-OGT-Induced G6PD Overactivation.
Su Z; Gao A; Li X; Zou S; He C; Wu J; Ding WQ; Zhou J
Front Oncol; 2021; 11():706337. PubMed ID: 34354953
[TBL] [Abstract][Full Text] [Related]
7. The expression of annexin-A1 in esophageal squamous cell carcinoma and its association with the biological behavior of the primary human esophageal squamous carcinoma cell line.
Li XJ; Li J; Zhang QQ; Su LP; Guo Y; Gong XL; Yao JJ; Wang L; Zhang ZQ
J Physiol Pharmacol; 2023 Oct; 74(5):. PubMed ID: 38085519
[TBL] [Abstract][Full Text] [Related]
8. Radiation-induced upregulation of FGL1 promotes esophageal squamous cell carcinoma metastasis via IMPDH1.
Huang S; Zhang J; He P; Cui X; Hou Y; Su W; Li F
BMC Cancer; 2024 May; 24(1):557. PubMed ID: 38702629
[TBL] [Abstract][Full Text] [Related]
9. IL-1RA inhibits esophageal carcinogenesis and lymphangiogenesis via downregulating VEGF-C and MMP9.
Shen Z; Zhang P; Zhang W; Luo F; Xu H; Chen S; Kang M
Funct Integr Genomics; 2023 May; 23(2):164. PubMed ID: 37198330
[TBL] [Abstract][Full Text] [Related]
10. An esophageal squamous cell carcinoma classification system that reveals potential targets for therapy.
Xiong T; Wang M; Zhao J; Liu Q; Yang C; Luo W; Li X; Yang H; Kristiansen K; Roy B; Zhou Y
Oncotarget; 2017 Jul; 8(30):49851-49860. PubMed ID: 28591712
[TBL] [Abstract][Full Text] [Related]
11. MBIP promotes ESCC metastasis by activating MAPK pathway.
Ma Y; Hua Y; Yin X; Jiao Y; Xu E; Yan T; Yang J; Zhang L
Cell Signal; 2024 Mar; 115():111040. PubMed ID: 38199596
[TBL] [Abstract][Full Text] [Related]
12. A2ML1 Inhibits Esophageal Squamous Cell Carcinoma Progression and Serves as a Novel Prognostic Biomarker.
Zhang X; Tang C; Lian J; Jiang Y
Can J Gastroenterol Hepatol; 2023; 2023():5557546. PubMed ID: 37954860
[TBL] [Abstract][Full Text] [Related]
13. NRG1 promotes tumorigenesis and metastasis and afatinib treatment efficiency is enhanced by NRG1 inhibition in esophageal squamous cell carcinoma.
Hou G; Niu T; Jia A; Zhang Y; Chen X; Wei H; Jia Y; Xu Y; Li Y; Wang P; Chatterjee A
Biochem Pharmacol; 2023 Dec; 218():115920. PubMed ID: 37989416
[TBL] [Abstract][Full Text] [Related]
14. ZPR1 is an immunodiagnostic biomarker and promotes tumor progression in esophageal squamous cell carcinoma.
Sun G; Ye H; Liu H; Li T; Li J; Zhang X; Cheng Y; Wang K; Shi J; Dai L; Wang P
Cancer Sci; 2024 Jan; 115(1):70-82. PubMed ID: 37964506
[TBL] [Abstract][Full Text] [Related]
15. The role of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 in esophageal squamous cell carcinoma.
Bao J; Wu Y; Wang L; Zhu Y
Medicine (Baltimore); 2020 Apr; 99(15):e19626. PubMed ID: 32282711
[TBL] [Abstract][Full Text] [Related]
16. NRF2/HO-1 axis, BIRC5, and TP53 expression in ESCC and its correlation with clinical pathological characteristics and prognosis.
Gao Y; Wan L; Li M; Wang B; Ma Y
Int J Biol Markers; 2023 Dec; 38(3-4):174-184. PubMed ID: 37312528
[TBL] [Abstract][Full Text] [Related]
17. Targeting WISP1 to sensitize esophageal squamous cell carcinoma to irradiation.
Zhang H; Luo H; Hu Z; Peng J; Jiang Z; Song T; Wu B; Yue J; Zhou R; Xie R; Chen T; Wu S
Oncotarget; 2015 Mar; 6(8):6218-34. PubMed ID: 25749038
[TBL] [Abstract][Full Text] [Related]
18. Increased matrix metalloproteinase activation in esophageal squamous cell carcinoma.
Mukherjee S; Roth MJ; Dawsey SM; Yan W; Rodriguez-Canales J; Erickson HS; Hu N; Goldstein AM; Taylor PR; Richardson AM; Tangrea MA; Chuaqui RF; Emmert-Buck MR
J Transl Med; 2010 Oct; 8():91. PubMed ID: 20920372
[TBL] [Abstract][Full Text] [Related]
19. NUAK1 promotes tumor metastasis through upregulating slug transcription in esophageal squamous cell carcinoma.
Yang H; Wei Z; Song Y; Du K; Yin N; Lu H; Li B; Hou L; Xing P; Chen L; Wang C; Xie S
Cancer Cell Int; 2023 Nov; 23(1):258. PubMed ID: 37919754
[TBL] [Abstract][Full Text] [Related]
20. High TRAF6 Expression Is Associated With Esophageal Carcinoma Recurrence and Prompts Cancer Cell Invasion.
Liu X; Wang Z; Zhang G; Zhu Q; Zeng H; Wang T; Gao F; Qi Z; Zhang J; Wang R
Oncol Res; 2017 Apr; 25(4):485-493. PubMed ID: 27697099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
